Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Enhancer box (E-box) is a conserved DNA sequence motif, typically defined by the hexanucleotide consensus CANNTG, which acts as a pivotal regulatory element in the eukaryotic genome [1]. In neuronal gene regulatory regions, E-boxes are essential for the recruitment of basic helix-loop-helix (bHLH) transcription factors such as ASCL1, NEUROD1, and the CLOCK-BMAL1 complex [2]. These interactions are fundamental to the control of neurogenesis, the specification of neuronal identity, and the regulation of the molecular circadian clock [1, 2]. While the E-box itself is a structural DNA component and not a protein, it serves as the functional site for transcriptional complexes that are frequently dysregulated in disease [3]. For instance, the overexpression of MYC family proteins in neuroblastoma leads to aberrant E-box occupancy and uncontrolled cell proliferation [4]. Therapeutic strategies targeting this pathway often focus on small molecules or mimetic peptides that disrupt the ability of bHLH proteins to dimerize or bind to the E-box motif [4]. Consequently, the E-box is a central feature of the gene regulatory networks targeted in the treatment of various cancers and neurological disorders. The ubiquity of these motifs across the genome presents a significant challenge for achieving therapeutic specificity without inducing widespread off-target effects. References: [1] Massari, M. E., & Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Molecular and Cellular Biology. [2] Bertrand, N., et al. (2002). Determinants of cell fate specification in the developing central nervous system. Nature Reviews Neuroscience. [3] Takahashi, J. S. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews Genetics. [4] Prochownik, E. V., & Vogt, P. K. (2010). Therapeutic Targeting of Myc. Genes & Cancer.
Inhibition of bHLH transcription factor dimerization or DNA binding
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enhancer box DNA motif (E-box) (E-box).